IGC Pharma(IGC)
$0.20+0.00 (+1.02%)
IGC
IGC Pharma financials statements
$0.20
At close:+0.00 (+1.02%)
Want to see IGC full AI Analyst Report?
IGC Pharma (IGC) Ratios
1,058 Followers
IGC Pharma Ratios
IGC's free cash flow for Q2 2027 was $-1.61M. For the 2027 fiscal year, IGC's free cash flow was decreased by $-193.00K and operating cash flow was $-1.42M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Jun 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.40 | 1.28 | 1.58 | 3.41 | 6.19 |
| Quick Ratio | 0.18 | 0.68 | 0.91 | 2.01 | 4.74 |
| Cash Ratio | 0.07 | 0.18 | 0.51 | 1.68 | 4.29 |
| Solvency Ratio | -2.12 | -2.75 | -4.79 | -4.79 | -4.88 |
| Operating Cash Flow Ratio | -2.07 | -2.12 | -2.22 | -3.71 | -3.06 |
| Short-Term Operating Cash Flow Coverage | -8.19 | -49.43 | -40.94 | 0.00 | -2487.33 |
| Net Current Asset Value | $ -1.92M | $ 479.00K | $ 1.12M | $ 4.20M | $ 12.17M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.10 | 0.03 | 0.04 | 0.03 | 0.02 |
| Debt-to-Equity Ratio | 0.15 | 0.04 | 0.05 | 0.03 | 0.03 |
| Debt-to-Capital Ratio | 0.13 | 0.04 | 0.05 | 0.03 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 |
| Financial Leverage Ratio | 1.50 | 1.38 | 1.35 | 1.15 | 1.12 |
| Debt Service Coverage Ratio | -8.94 | -68.63 | -72.13 | 0.00 | -4788.33 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.04 | 0.01 | 0.01 | 0.01 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 |
| Net Debt to EBITDA | -0.11 | 0.02 | 0.09 | 0.25 | 0.69 |
| Profitability Margins | |||||
| Gross Profit Margin | 29.68% | 48.70% | 54.50% | -17.34% | 48.87% |
| EBIT Margin | -552.11% | -560.27% | -728.48% | -1263.01% | -3782.37% |
| EBITDA Margin | -547.22% | -523.76% | -681.12% | -1190.89% | -3618.39% |
| Operating Profit Margin | -860.29% | -585.84% | -728.48% | -1270.14% | -3886.15% |
| Pretax Profit Margin | -552.11% | -560.27% | -966.54% | -1263.01% | -3782.37% |
| Net Profit Margin | -552.11% | -560.27% | -966.54% | -1263.01% | -3782.37% |
| Continuous Operations Profit Margin | -552.11% | -560.27% | -966.54% | -1263.01% | -3782.37% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 64.18% | 95.64% | 132.68% | 99.44% | 97.33% |
| Return on Assets (ROA) | -71.29% | -81.41% | -131.29% | -66.98% | -55.96% |
| Return on Equity (ROE) | -106.98% | -112.50% | -177.57% | -77.16% | -62.85% |
| Return on Capital Employed (ROCE) | -161.64% | -114.73% | -129.57% | -75.73% | -63.25% |
| Return on Invested Capital (ROIC) | -144.79% | -113.04% | -127.43% | -75.07% | -62.92% |
| Return on Tangible Assets | -167.17% | -103.28% | -156.89% | -71.88% | -57.94% |
| Earnings Yield | -26.20% | -32.65% | -46.42% | -64.46% | -31.65% |
| Efficiency Ratios | |||||
| Receivables Turnover | 32.05 | 16.51 | 34.49 | 8.51 | 0.66 |
| Payables Turnover | 0.66 | 0.74 | 0.79 | 2.02 | 0.21 |
| Inventory Turnover | 1.31 | 0.48 | 0.39 | 0.40 | 0.06 |
| Fixed Asset Turnover | 0.56 | 0.38 | 0.35 | 0.11 | 0.04 |
| Asset Turnover | 0.13 | 0.15 | 0.14 | 0.05 | 0.01 |
| Working Capital Turnover Ratio | -2.18 | 1.27 | 0.45 | 0.11 | 0.02 |
| Cash Conversion Cycle | -258.64 | 289.14 | 492.48 | 767.07 | 5164.42 |
| Days of Sales Outstanding | 11.39 | 22.11 | 10.58 | 42.87 | 548.88 |
| Days of Inventory Outstanding | 279.22 | 761.35 | 942.92 | 905.16 | 6379.41 |
| Days of Payables Outstanding | 549.25 | 494.32 | 461.02 | 180.96 | 1763.87 |
| Operating Cycle | 290.61 | 783.46 | 953.50 | 948.03 | 6928.29 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.06 | -0.06 | -0.09 | -0.13 | -0.15 |
| Free Cash Flow Per Share | -0.06 | -0.07 | -0.10 | -0.15 | -0.16 |
| Dividend Paid and CapEx Coverage Ratio | -36.24 | -9.95 | -10.10 | -11.38 | -9.68 |
| Capital Expenditure Coverage Ratio | -36.24 | -9.95 | -10.10 | -11.38 | -9.68 |
| Operating Cash Flow Coverage Ratio | -6.42 | -19.90 | -14.94 | -14.65 | -12.21 |
| Operating Cash Flow to Sales Ratio | -5.01 | -3.77 | -3.87 | -7.74 | -18.80 |
| Free Cash Flow Yield | -24.43% | -24.20% | -20.40% | -42.95% | -17.36% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.64 | -3.06 | -2.15 | -1.55 | -3.16 |
| Price-to-Sales (P/S) Ratio | 21.08 | 17.16 | 20.82 | 19.59 | 119.49 |
| Price-to-Book (P/B) Ratio | 4.08 | 3.45 | 3.83 | 1.20 | 1.99 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.09 | -4.13 | -4.90 | -2.33 | -5.76 |
| Price-to-Operating Cash Flow Ratio | -4.21 | -4.55 | -5.39 | -2.53 | -6.36 |
| Price-to-Earnings Growth (PEG) Ratio | 0.16 | 0.05 | 0.00 | 0.06 | -0.07 |
| Enterprise Value Multiple | -3.96 | -3.25 | -2.96 | -1.40 | -2.62 |
| Enterprise Value | 25.71M | 21.64M | 27.16M | 15.13M | 37.59M |
| EV to EBITDA | -3.96 | -3.25 | -2.96 | -1.40 | -2.62 |
| EV to Sales | 21.68 | 17.03 | 20.19 | 16.61 | 94.68 |
| EV to Free Cash Flow | -4.21 | -4.10 | -4.75 | -1.97 | -4.57 |
| EV to Operating Cash Flow | -4.33 | -4.51 | -5.22 | -2.15 | -5.04 |
| Tangible Book Value Per Share | 0.01 | 0.06 | 0.10 | 0.26 | 0.46 |
| Shareholders’ Equity Per Share | 0.06 | 0.08 | 0.12 | 0.28 | 0.48 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 |
| Net Income Per Share | -0.07 | -0.09 | -0.22 | -0.22 | -0.30 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.33 | 1.00 | 1.00 |
| Research & Development to Revenue | 4.38 | 2.88 | 2.81 | 3.80 | 5.87 |
| SG&A to Revenue | 4.52 | 3.47 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.38 | 1.29 | 1.32 | 3.12 | 5.53 |
| Income Quality | 0.91 | 0.67 | 0.40 | 0.61 | 0.50 |
Currency in USD
